SOCS1 and neoplasm: Next, we explored whether SOCS1 could be an important molecular marker in predicting the clinical outcome of HCC patients and found that the tumour-free survival in HCC patients with high SOCS1 expression was significantly higher than that in patients with low SOCS1 expression (P = .0042, Figure 5F).